• Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 158

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Tricia Eastman: Seeding Consciousness, Ancestral Wisdom, and Psychedelic Initiation

Psilocybe Mushroom Pickers in Britain

Pα+ Psychedelic Bulletin #216: Australia’s Psychedelics-for-Veterans Funding; New Mexico Targets 2026 Medical Psilocybin Launch; Radial Scores $50M; Otsuka’s “Novel Serotonergic Agonists”; Psilocybin Accelerates Brain...

The Psychedelic News Feed: December 8 – 14, 2025

The Psychedelic Practitioner Issue 2: Preparation

COMPASS Pathways to participate in upcoming BTIG Biotechnology Conference and Canaccord...

Braxia Scientific Reports Fourth Quarter and FY 2022 Financial Results

atai Life Sciences to Announce Second Quarter 2022 Financial Results and...

BREAKING: Morgan Stanley Publishes Optimistic Report on Psychedelics

Algernon Pharmaceuticals Reports Additional Positive Data From its Phase 2 Study...

FILAMENT HEALTH ANNOUNCES PARTICIPATION IN PROJECT SOLACE

PT342 – Spencer Hawkswell – The Right to Psilocybin in Canada:...

Psychedelic Bulletin #112 – Inside the DEA Challenge; Second Psychedelics Company...

Inside the Challenge to DEA’s Proposed Scheduling of 5 Psychedelic Tryptamines

COMPASS Pathways launches phase II clinical trial of psilocybin therapy in...

1...157158159...304Page 158 of 304

EDITOR PICKS

Tricia Eastman: Seeding Consciousness, Ancestral Wisdom, and Psychedelic Initiation

Psilocybe Mushroom Pickers in Britain

Pα+ Psychedelic Bulletin #216: Australia’s Psychedelics-for-Veterans Funding; New Mexico Targets 2026...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    ©